4[3]Barnett AH, Owens DR. Insulin analogues. Lancet. 1997; 349:47
5[4]Home P, Lindholm A, RiisA. European Insulin Aspart study Group, Insulin aspart vs human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus : a randomized controlled trial. Diabetic Med. 2000; 17:762
6[5]Raskin P, Guthrie R, Leiter L, et al. Use of insulin aspart, a fast- acting insulin analog, as the meattime insulin in the management of patients with type 1 diabetes. Diabetes Care. 2000; 23: 583
7[6]Tamas G, Marre M, Astorga R, et al. Glycaemic control in type 1diabetic patients using optimized insulin aspart or human insulin in a randomized mutinational study. Diabetes Res Clin Pract .2001; 54:105
8[7]Galloway JA, Frank BH Hooper SA, et al. Biosynthetic human proinsulin. Diabetes Care、 1992; 15:666
9[8]Riddle MC, Rosenstock J, Gerich J. The treat - to - target trail.Diabetes Care. 2003: 26: 3080
10[9]Jahansson BL, Wahren J, Pernow J. C - peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide dependent mechanism. Am J physiol Endocrinol Metab. 2003;285: E864
9SAJU SE, ELLEN LC, JAMES EG. Insulin desensitization with insulin lispro and an insulin pump in 5 year old child. Ann Allergy Asthma lmmunol 2000;85(5) :395-397.
